Lung Cancer Trial, Recruiting NCT06070870 Sponsor: Virginia Commonwealth University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06070870
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You meet the current US guidelines for lung cancer screening (confirm with trial site if unsure whether you qualify)
  • You have smoked at least 20 pack-years in your lifetime (for example, one pack per day for 20 years, or two packs per day for 10 years)
  • You currently smoke, or you quit smoking within the last 15 years
  • You identify as Black or African-American (including people who are also Hispanic/Latino, such as Afro-Latino)
  • You are willing to take part in all study activities related to patient navigation support
  • You are able to understand and sign a written consent form agreeing to participate

Who may not be able to join:

  • You have a history of cancer (other than a type of skin cancer called squamous cell skin cancer), or you have coughed up blood at any point in the last 5 years
  • You have already had a lung cancer screening in the past
  • You are not able to speak English
  • You have a medical, mental health, or social situation that the study doctor feels could put you at risk or make it difficult to fully participate in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vanessa Sheppard, PhD, Virginia Commonwealth University

Phone: 804-628-6430

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 October 2023
Est. completion
30 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of study patients who complete lung cancer screening (LCS) through the patient navigation process

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov